Dechra Pharmaceuticals PLC
15 January 2008
Issued by Citigate Dewe Rogerson Ltd, Birmingham
Tuesday 15 January 2008
Immediate Release
Dechra(R) Pharmaceuticals PLC
Completion of acquisition
Dechra Pharmaceuticals PLC ('Dechra' or 'Group') announces that it has
successfully completed the acquisition of VetXX Holding A/S, a leading
developer, producer and marketer of companion animal veterinary products, for a
total consideration of £61.7m.
Details of the Acquisition and Placing were announced on 12 December 2007. Full
details are contained in the Prospectus which can be found on the Group's
website.
Enquiries:
Ian Page, Chief Executive Fiona Tooley, Director
Simon Evans, Group Finance Director Keith Gabriel, Senior Account Manager
Dechra Pharmaceuticals PLC Citigate Dewe Rogerson
Tel: +44 (0) 1782 771100 Tel: +44 (0) 121 455 8370
Mobile: +44 (0)7785 703523 (FMT)
www.dechra.com
corporate.enquiries@dechra.com
Trade Marks appear throughout this release in italics. Dechra and the Dechra '
D' logo are registered
Trade Marks of Dechra Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.